Summary of Department

In our department, we carefully evaluate the cardiac function before performing surgical operations or starting chemotherapy and/or radiotherapy. We also provide optimal control of pre-existing cardiovascular risk factors.

Recently, advances in treatments have improved the survival of patients with cancer. However, they have conversely led to increased morbidity and mortality due to treatment side effects. Chemotherapy and radiotherapy can put patients at risk of a variety of cardiovascular complications, including heart failure, coronary artery disease, venous thromboembolism, peripheral artery disease, pericardial disease and valvular disease. Cardiovascular complications often limit therapeutic options for many treatable and potentially curable cancers. Therefore, the field of cardio-oncology has received attention in recent years. We assess patients with cancer at baseline to define their risk of cardiotoxicity and then follow them closely during and after chemotherapy to detect early signs or symptoms of cardiovascular disease.

In cooperation with oncologists, we support the cancer treatment of each patient in our hospital.

Main scope of the treatment

Main target diseases:

Myocardial dysfunction and heart failure, ischemic heart disease
Venous thromboembolism, arrhythmias (e.g. atrial fibrillation, paroxysmal supraventricular tachycardia, etc.), pericardial complications (pericardial effusion, cardiac tamponade), arterial hypertension, hyperlipidemia

Technique:

Electrocardiogram, Holter electrocardiography, exercise electrocardiography, transthoracic echocardiography, transesophageal echocardiography, vascular ultrasonography, stress echocardiography, coronary computed tomography